150 related articles for article (PubMed ID: 15563240)
21. A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy.
Coutsouvelis J; Corallo C; Spencer A; Avery S; Dooley M; Kirkpatrick CM
Crit Rev Oncol Hematol; 2022 Apr; 172():103606. PubMed ID: 35101586
[TBL] [Abstract][Full Text] [Related]
22. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation.
Dörr W; Reichel S; Spekl K
Radiother Oncol; 2005 Apr; 75(1):99-105. PubMed ID: 15878107
[TBL] [Abstract][Full Text] [Related]
23. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
Raber-Durlacher JE; von Bültzingslöwen I; Logan RM; Bowen J; Al-Azri AR; Everaus H; Gerber E; Gomez JG; Pettersson BG; Soga Y; Spijkervet FK; Tissing WJ; Epstein JB; Elad S; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):343-55. PubMed ID: 22987094
[TBL] [Abstract][Full Text] [Related]
24. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality.
Farrell CL; Bready JV; Rex KL; Chen JN; DiPalma CR; Whitcomb KL; Yin S; Hill DC; Wiemann B; Starnes CO; Havill AM; Lu ZN; Aukerman SL; Pierce GF; Thomason A; Potten CS; Ulich TR; Lacey DL
Cancer Res; 1998 Mar; 58(5):933-9. PubMed ID: 9500453
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
26. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
27. In silico enhancement of the stability and activity of keratinocyte growth factor.
Poorebrahim M; Sadeghi S; Ghorbani R; Asghari M; Abazari MF; Kalhor H; Rahimi H
J Theor Biol; 2017 Apr; 418():111-121. PubMed ID: 28093295
[TBL] [Abstract][Full Text] [Related]
28. Keratinocyte Growth Factor (KGF) in hematology and oncology.
MacDonald KP; Hill GR
Curr Pharm Des; 2002; 8(5):395-403. PubMed ID: 12069377
[TBL] [Abstract][Full Text] [Related]
29. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.
Danilenko DM; Ring BD; Yanagihara D; Benson W; Wiemann B; Starnes CO; Pierce GF
Am J Pathol; 1995 Jul; 147(1):145-54. PubMed ID: 7604876
[TBL] [Abstract][Full Text] [Related]
30. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.
Finch PW; Mark Cross LJ; McAuley DF; Farrell CL
J Cell Mol Med; 2013 Sep; 17(9):1065-87. PubMed ID: 24151975
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
Bradstock KF; Link E; Collins M; Di Iulio J; Lewis ID; Schwarer A; Enno A; Marlton P; Hahn U; Szer J; Cull G; Seymour JF;
Br J Haematol; 2014 Dec; 167(5):618-25. PubMed ID: 25142189
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory effects of palifermin (recombinant human keratinocyte growth factor) in an SLE-like model of chronic graft-versus-host disease.
Ellison CA; Lissitsyn YV; Gheorghiu I; Gartner JG
Scand J Immunol; 2012 Jan; 75(1):69-76. PubMed ID: 21916922
[TBL] [Abstract][Full Text] [Related]
33. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
[TBL] [Abstract][Full Text] [Related]
34. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.
Blijlevens N; Sonis S
Ann Oncol; 2007 May; 18(5):817-26. PubMed ID: 17030544
[TBL] [Abstract][Full Text] [Related]
35. Recombinant Human Keratinocyte Growth Factor Ameliorates Cancer Treatment-Induced Oral Mucositis on a Chip.
Ly KL; Rajtboriraks M; Elgerbi A; Luo X; Raub CB
Adv Healthc Mater; 2024 Jun; 13(14):e2302970. PubMed ID: 38351394
[TBL] [Abstract][Full Text] [Related]
36. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
[TBL] [Abstract][Full Text] [Related]
37. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
[TBL] [Abstract][Full Text] [Related]
38. Acanthosis nigricans in a patient treated with palifermin.
Lee M; Grassi M
Cutis; 2010 Sep; 86(3):136-7. PubMed ID: 21049730
[TBL] [Abstract][Full Text] [Related]
39. Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients.
Liu D; Seyboth B; Mathew S; Gilheeney SW; Chou AJ; Drill E; Kobos R
J Pediatr Hematol Oncol; 2017 May; 39(4):e177-e182. PubMed ID: 28234746
[TBL] [Abstract][Full Text] [Related]
40. Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases.
Vitale KM; Violago L; Cofnas P; Bishop J; Jin Z; Bhatia M; Kung AL; George D; Garvin J; Satwani P
Pediatr Transplant; 2014 Mar; 18(2):211-6. PubMed ID: 24823628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
